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Abstract 
The paper studies the current COVID-19 pandemic by applying an adapted epidemiologic 
model, where each individual is in one of the five states “susceptible”, “infected”, “removed”, 
“immune healthy” or “dead”. We extend the basic model with time-invariant transition rates 
between these states by allowing for time-dependent infection rates as a consequence of 
lockdowns and social distancing policies as well as for time-dependent mortality rates as a result 
of changing infection patterns. Our model proves to be appropriate to calibrate and simulate the 
dynamics of COVID-19 pandemic in Germany between January and October 2020. We provide 
deeper insights about some key indicators such as the reproduction number, the effectiveness 
of non-pharmaceutical interventions, and the development of the infection and mortality rates. 
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1.  Introduction 
Infections with the coronavirus SARS-CoV-2, short for “severe acute respiratory syndrome 
coronavirus 2” first appeared in Wuhan/China in early December 2019 (Wu et al., 2020), 
causing the disease COVID-19 (WHO, 2020b). Since then the virus is spreading continuously 
over the world population, leading not only to millions of infections and hundreds of thousands 
of deaths (WHO, 2020f) but also having the potential to cause a global economic downturn 
such as the world has not experienced since 75 years (World Bank, 2020). According to the 
data provided by the Johns Hopkins University Center for Systems Science and Engineering 
(JHU CSSE)1, there are more than a total of 38 million reported cases worldwide that occurred 
since the beginning in January until mid-October 2020. Despite a variety of public life 
restrictions such as mask wearing or social distancing, the virus still persists in most parts of 
the world (JHU CSSE, 2020). 
To model the dynamics of infectious diseases, scientists usually apply the SIR model, which is 
short for “susceptible” S, “infected” I, and “removed” R. Indeed, this model has a long history 
of successfully simulating the spread of several types of diseases over the last hundred years, 
ranging from smallpox to measles to seasonal influenza viruses (Hethcote, 2008). At least two 
aspects of the current corona crisis make an extension of the original SIR model necessary: 
First, COVID-19 is a disease that is fatal for about 1% of infected individuals (compare Davies 
et al., 2020; Pastor-Barriuso et al., 2020; Russell et al., 2020; Salje et al., 2020; Verity et al., 
2020; Ward et al., 2020). Second, governments imposed several interventions aimed at reducing 
the transmission of the virus and as a result, infection levels as well as deaths rates were 
significantly reduced  (Flaxman et al., 2020). Therefore, we extend the basic SIR model (i) by 
taking into account the transition processes from “removed” R to “dead” D or to “immune 
healthy” H, and (ii) by allowing for time-dependent infection and mortality rates due to 
governmental interventions as well as behavioral adaptations of people. 
The aim of our study is to explain and to simulate the dynamics of the SARS-CoV-2 pandemic 
in Germany between January and October 2020. Thereby, we provide insights about some key 
indicators such as the reproduction number, the effectiveness of non-pharmaceutical 
interventions and the infection fatality rate. 
                                                 
1 The John Hopkins University provides a constantly updated COVID-19 data set as developed by Dong et al. 
(2020) in February 2020 in order to demonstrate the development of the global case numbers. 
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The rest of the paper is organized as follows: Section 2 presents an overview of the development 
of the coronavirus and provides information about the most important characteristics of the 
current COVID-19 disease which is not only crucial for being up to date with the state-of-the-
art research but even more for designing an appropriate pandemic model. In Section 3, we 
describe the spread of the virus in Germany between January and October 2020. Section 4 
presents our version of the SIRDH model and derives some important indicators such as the 
reproduction number and the infection level needed for herd immunity. In Section 5, we apply 
this model to the pandemic development in Germany, including different scenarios such as an 
uncontrollable spread of COVID-19 compared to the actual development. Finally, Section 6 
concludes the paper. 
2.  The Background of the Pandemic 
In this section, we provide an overview of the pandemic background of the corona crisis. First, 
we report on the development and the status quo of the pandemic and afterwards we summarize 
the key characteristics of COVID-19. 
2.1. Development and Status Quo 
SARS-CoV-2 is related to previous coronaviruses like SARS-CoV or MERS-CoV that occurred 
in 2003 and 2012, respectively (Petersen et al., 2020)2. While there are still research efforts to 
clarify the origin of the new coronavirus, currently it is believed that the virus can be traced 
back to animals, likely bats, with the exact route of transmission for the first human infection 
being still unclear (WHO, 2020c).  
Starting point of the spread of the novel virus is believed to be late December 2019 with many 
cases tracing back to the seafood market in the city of Wuhan (WHO, 2020c). From there on, 
the coronavirus spread within the Hubei region and also reached China’s neighboring countries 
such as Thailand, Japan and South Korea that all reported first cases until the 20th of January, 
2020 (WHO, 2020a). Soon, Europe was affected by the virus with the first officially confirmed 
cases reported in France at the 24th of January, 2020 (Spiteri et al., 2020; Stoecklin et al., 2020). 
However, compared to China, total infections in Europe and the rest of the world remained 
relatively low during the following weeks. On the 11th of March, when the WHO decided to 
declare the crisis as a pandemic, almost 70% of the 118,000 global infections were still 
attributed to China (WHO, 2020d). However, this picture changed. While China successfully 
                                                 
2 See also Petersen et al. (2020) for similarities and differences between previous coronavirus outbreaks, influenza 
viruses and COVID-19. 
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reduced the spreading of the virus through governmental interferences (Tian et al., 2020), the 
pandemic unfolded its full impact in Europe where total infections already exceeded 
documented cases in Asia in late March 2020 (ECDC, 2020).  
An important parameter in epidemiology is the basic and effective reproduction number, 
denoted here as 𝑅𝑅0 and 𝑅𝑅𝑒𝑒 respectively. The basic reproduction number can be defined as “the 
average number of secondary cases produced by one infected individual introduced into a 
population of susceptible individuals” (van den Driessche, 2017, p. 289). In the case of the 
novel corona virus, 𝑅𝑅0 is estimated to lie between 2 and 3 (Y. Liu et al., 2020; Tian et al., 2020; 
WHO, 2020c). In other words, this indicates that an infected individual infects on average 
between two and three persons during his or her illness. 𝑅𝑅0 denotes the reproduction number at 
the very beginning of an outbreak, whereas 𝑅𝑅𝑒𝑒 represents the actual value of the reproduction 
number and thus varies over time (Chowell et al., 2004). The importance of these 
epidemiological parameters rely on the fact, that a reproduction number above 1 leads to the 
potential of a pandemic with many infections, whereas a reproduction number below 1 makes 
an infectious disease disappear in the long run (van den Driessche, 2017). 
In fact, there are three possibilities to reduce the reproduction number and to reach a 
controllable level of COVID-19 infections: First, governments can rely on so-called non-
pharmaceutical interventions (NPIs) (Ferguson et al., 2020). NPIs can best be described with 
the term “social distancing” (R. M. Anderson et al., 2020). This generic term includes a variety 
of measures, all of which aim to either bring infected and uninfected persons together at a lower 
rate or to keep a certain physical distance to make a transmission less likely. Social distancing 
policies used in the COVID-19 pandemic are for example school and business closures, ban of 
mass gatherings, closing of borders or curfews (see You Li et al. (2020) for the use and 
effectiveness of these NPIs). During the first wave3 of the pandemic, many European countries 
followed a lockdown4 strategy that led to a decline of the reproduction number of more than 
80% (Flaxman et al., 2020). In New Zealand, a suppression strategy not only reduced the 
reproduction number but even led to zero new cases in early May 2020 (Cousins, 2020). In 
addition, there is also evidence that interventions such as wearing a mask or keeping minimum 
distances between persons, can also contribute to hinder the virus from spreading. In their meta-
analysis study, Chu et al. (2020) estimate that the risk of transmission is five times less likely 
if individuals keep a distance of more than one meter with even greater effects if distances are 
larger. While the effectiveness to stop the virus from spreading depends on the mask type (Chu 
                                                 
3 Understood as the time between March and April 2020 characterized by relatively high infection levels. 
4 Lockdown is understood as a broad term for various social distancing policies implemented at the same time. 
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et al., 2020), experiments by Fischer et al. (2020) show that already surgical face masks or 
simple cotton masks can have an impact on reducing droplet transmission. Moreover, despite 
this experimental evidence there are also studies that analyze the development in various 
regions such as the city of Jena (Mitze et al., 2020) or New York, Wuhan and Italy (Zhang et 
al., 2020) with the conclusion that mask wearing in public is associated with a decline in case 
numbers.  
As a note, studies also point out the risks of scenarios in which governments would have not 
decided to fight the spread of COVID-19. For example, Ferguson et al. (2020) estimate that in 
the UK and the US, about 80% of the population would have been infected within four months. 
The situation presented in such a scenario would not only lead to an overload of the health care 
system but cause several hundreds of thousands of deaths (Ferguson et al., 2020). This is 
supported by another study of Flaxman et al. (2020) which suggests that without social 
distancing, total deaths in the five biggest European countries (France, Germany, Italy, UK, and 
Spain) could have been in total above 2.9 million already in early May 2020. 
Another approach to fight the virus is the so-called mitigation strategy with the long-term goal 
to reach herd immunity (Drozd & Tavares, 2020). Herd immunity is reached when the majority 
of the population got exposed to the virus – implying immunity against a re-infection – and thus 
with less and less individuals being susceptible to the virus, the spread of the virus eventually 
declines (Hethcote, 2008). However, there are certain risks and drawbacks associated with a 
mitigation strategy. On the one hand, as Ferguson et al. (2020) and Bock et al. (2020) point out, 
mitigation strategies aiming at acquiring herd immunity within a short time period are hardly 
applicable for COVID-19, as the number of intensive care patients and deadly outcomes would 
be too high for health systems to handle. On the other hand, studies show that generated 
antibodies might disappear several weeks after an infection (Ibarrondo et al., 2020; Seow et al., 
2020). Indeed, the study by To et al. (2020) confirmed that it is possible to be infected again 
after being exposed to the virus. 
Moreover, many so-called seroprevalence studies that analyze the existence of antibodies point 
in the same direction: While the extent to which the population of European countries got 
exposed to the virus in Spring 2020 is significantly larger than documented by national health 
authorities or institutions such as the Johns Hopkins University, total infection levels are still 
in the single digit percentage area and therefore too low to constitute an effective barrier to 
hinder the virus from spreading (Flaxman et al., 2020; Pollán et al., 2020; RKI, 2020f; Salje et 
al., 2020).  
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However, herd immunity might be reached with the help of vaccination. In general, vaccine 
development is characterized by two different stages, namely the pre-clinical and clinical stage, 
followed by a market entry after the vaccine is approved by the concerning regulatory institution 
(Pronker et al., 2013). On average, such a process is estimated to take about ten years with an 
average success rate of 6% (Pronker et al., 2013). However, in the case of COVID-19, these 
gradual development steps are speeded up and clinical trials did already start as soon as March 
2020 (Lurie et al., 2020). According to an overview provided by the WHO (2020f), in October 
2020 almost 200 vaccine manufactures and research institutes were working on the 
development of vaccines for COVID-19 and there are in total ten companies currently testing 
their product in the last out of three clinical trial stages (WHO, 2020e). However, it remains 
speculative whether approved vaccines will be available already in late 2020 as expressed by 
Agrawal et al. (2020) or only in 2021 (R. M. Anderson et al., 2020).  
In sum, herd immunity via infection or vaccination remains rather unlikely in autumn and 
winter 2020. When effective social distancing measures are cancelled at an insufficiently high 
level of immunity in the population, then a resurrection of COVID-19 cases is a likely scenario 
(R. M. Anderson et al., 2020; Ferguson et al., 2020; Salje et al., 2020). In fact, according to the 
numbers provided by JHU CSSE (2020), after most European countries overcame the first wave 
of corona virus infections, COVID-19 resurged in the late Summer 2020 on the continent with 
case numbers starting to increase again, thereby reaching or exceeding similar daily detected 
case numbers as in March and April 2020.  
2.2. Key Characteristics of COVD-19 
The novel coronavirus is either transmitted directly from one individual to another (Chan et al., 
2020; Ghinai, McPherson, et al., 2020) or through contaminated objects – so called fomites 
(WHO, 2020c). When it comes to the transmission from one person to another, the virus passes 
from an infected to a susceptible individual via so-called droplets or aerosols (Prather et al., 
2020). Infection via droplets mainly occurs through coughing or sneezing whereby the infected 
person is close to other uninfected individuals (Asadi et al., 2020). In contrast to those rather 
large droplets, aerosols are smaller and remain in the air much longer with the possibility to 
travel several meters (Prather et al., 2020). At the beginning of the pandemic, aerosol 
transmission was believed to be only a minor factor (WHO, 2020c), however, recently 
published studies suggest otherwise (see e.g. E. L. Anderson et al., 2020; Lednicky et al., 2020; 
Yuguo Li et al., 2020; Morawska & Cao, 2020; Zhang et al., 2020). In general, indoor 
environments are associated with a higher probability of a virus transmission (Morawska & 
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Cao, 2020) with estimations suggesting that an infection with SARS-CoV-2 may be more than 
ten times as likely as compared to an outdoor environment (Nishiura et al., 2020). Especially 
overcrowded rooms and insufficient ventilation are a breeding ground for virus infections 
(Yuguo Li et al., 2020; Morawska & Cao, 2020; Nishiura et al., 2020). There exist many reports 
tracing back infections to single events or clusters such as nightclubs (Kang et al., 2020), parties 
or even funerals (Ghinai, Woods, et al., 2020), indoor restaurant visits (Lu et al., 2020), sport 
groups (Jang et al., 2020), choirs (Hamner et al., 2020), schools (Stein-Zamir et al., 2020), 
business meeting rooms or religious facilities like churches (Pung et al., 2020), or cruise ships 
like the Diamond Princess (Tabata et al., 2020).  
The symptoms of corona patients vary in degree of severity ranging from mild to severe 
symptoms even leading to death and there are no unique symptoms indicating an infection by 
COVID-19 (WHO, 2020c). However, some symptoms seem to occur more frequently than 
others. As the investigation of several symptomatic corona patients by Lechien et al. (2020) and 
Zhu et al., (2020) for Europe and China suggest, the most common symptoms are among others 
headache, cough, fever, loss of smell or taste or muscle soreness. Patients also report long term 
damages such as lasting fatigue (Arnold et al., 2020; Carfì et al., 2020). In contrast, about 33% 
of infected may overcome an infection without experiencing symptoms at all (Pollán et al., 
2020; Ward et al., 2020).  
In general, existing pre-conditions (such as diabetes or chronic lung diseases), an unhealthy 
way of life and being of higher age are associated with an increased risk for COVID-19, 
meaning those individuals have a higher probability of needing additional treatment in hospitals 
or dying in the course of the disease (CDC, 2020; Hamer et al., 2020; Verity et al., 2020). On a 
global and regional level, the study by Clark et al. (2020) estimates which fraction of a 
population may have a higher probability to experience a severe disease progression due to pre-
existing conditions or age. These results suggest that about one in five individuals worldwide 
could experience severe symptoms in the course of a SARS-CoV-2 infection and about four out 
of 100 infected would need to be transferred to an hospital (Clark et al., 2020). Especially for 
Germany, due to a higher proportion of elderly in the population, the estimations by Clark et 
al. (2020) are slightly higher compared to world average. However, simply being young and 
healthy does not imply that those individuals remain unaffected by the virus. There are also 
reported cases in which healthy children needed treatment in hospitals (Götzinger et al., 2020). 
Moreover, it is crucial to know how many people die from or with COVID-19. One way to 
measure the mortality rate of the corona virus is to use the so-called case fatality rate (CFR), 
which is the ratio between the total number of deaths and official confirmed cases (Vanella et 
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al., 2020). The CFR of early October 2020 for Germany ranks according to JHU CSSE, (2020) 
at 2.8%, which is in the range of other European countries such as France (4.0%) or Spain 
(3.6%), but significantly lower than for example the relative high rate of Italy of about 9.5%. 
However, there are many drawbacks associated with using the CFR in the case of COVID-19. 
First, differences in the amount of testing or age distributions may explain discrepancies and 
thus make the CFR unsuitable to compare different countries (Vanella et al., 2020). Second, the 
CFR does not account for undocumented cases (Streeck et al., 2020). Consequently, this rate 
may overestimate the lethality of COVID-19 (Russell et al., 2020). Therefore, one can use the 
so-called infection fatality rate (IFR) which can be defined as “the average number of deaths 
per infection” (Perez-Saez et al., 2020, p. 1). Estimations suggest an overall IFR of 
approximately between 0.5% and 1.3% for various countries such as the UK, France, China and 
Spain (Davies et al., 2020; Pastor-Barriuso et al., 2020; Russell et al., 2020; Salje et al., 2020; 
Verity et al., 2020; Ward et al., 2020). Up to this date, there is no peer-reviewed study proposing 
an IFR especially for Germany as a whole. A pre-print study by Streeck et al. (2020) estimates 
a range between 0.36% and 0.41% for the North Rhine-Westphalian municipality of Gangelt 
and is therefore below the reported numbers above. It is important to note that the IFR strongly 
differs with respect to age. In one study the IFR for those younger than 60 is below 0.2%, for 
those aged older than 60 is approximately 3.3% and those being aged 80 or older are at an 
especially high risk with an IFR of 7.8% (Verity et al., 2020)5.  
The duration of the disease depends on the degree of severity with those experiencing only mild 
symptoms needing approximately between one and two weeks to recover, whereas those 
individuals with very serious disease progression may need up to six weeks to be symptom free 
(WHO, 2020c). However, experiencing symptoms for several weeks does not automatically 
imply that these patients are also infectious for the same period (Boscolo-Rizzo et al., 2020). 
Analyses suggest an average infectivity period between seven and ten days after the 
development of symptoms with the degree of infectivity being significantly lower at the end of 
the infectious period (He et al., 2020; Kampen et al., 2020; Singanayagam et al., 2020; Wölfel 
et al., 2020). 
                                                 
5 While the estimated numbers in similar studies slightly differ (compare Pastor-Barriuso et al., 2020; Russell et 
al., 2020; Salje et al., 2020; Verity et al., 2020), those studies clearly indicate that the mortality risk for the younger 
population is relatively low whereas the older generation has a relatively high risk of deceasing in the course of 
the disease. 
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3.  The Phases of COVID-19 in Germany 
In order to calibrate the model, we have to distinguish at least three different phases of the 
pandemic: Phase I captures the period before the lockdown when the pandemic spread out 
without important policy measures to reduce the infection rate. This case will be captured by 
the basic SIRDH model with time-invariant transition rates. Phase II corresponds to the 
lockdown period and phase III refers to the period in which the policy measures have been 
partly relaxed leading to a slow, but steady revival of active case numbers. These two phases 
will be captured by an extended SIRDH model with time-dependent transition rates. This 
division into three different phases is illustrated in Figure 1. 
 
 
Figure 1: Development of Active COVID-19 Cases Divided into Three Different Phases 
 
3.1. Phase I: The Pre-Lockdown Development 
According to the data provided by JHU CSSE (2020), the first officially reported COVID-19 
case already occurred at 27th of January 2020, but recorded case numbers only slightly increased 
such that, in late February, only 20 cases in total were officially reported. However, this picture 
totally changed in the following weeks. Notably, early March was associated with two 
superspreading events. First, while total infections were still below 300, over 40% of the 
reported cases were attributed to a carnival party in the Heinsberg region of Nord-Rhine-
Westphalia (RKI, 2020a). Second, many infections occurred in Ischgl/Austria which is a 
popular skiing resort. This place is also associated with contributing to the spread of the virus 
after the German tourists returned from their holidays (Felbermayr et al., 2020).  
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Eventually, the number of cases rapidly increased and after total infections exceeded the one- 
thousand-mark on the 8th of March, it only took ten days to surpass a total of ten thousand 
confirmed infections (JHU CSSE, 2020). According to Hartl et al. (2020), in the first three 
weeks of March 2020, confirmed cases duplicated within three days and the number of new 
infections increased by approximately 27% per day. There are several scenario analyses 
pointing out that an overwhelming of the health care system associated with a huge number of 
deaths could have occurred if the German governments would have not decided to interfere via 
various social distancing policies. For example the estimations by Flaxman et al. (2020) 
suggest, that without any restrictions at all, Germany could have experienced more than 500,000 
deaths in early May. In addition, the Ministry of the Interior discussed several scenarios for the 
COVID-19 development in Germany and estimated that more than 300,000 beds in intensive 
care units could have been needed (BMI, 2020). 
 
3.2. Phase II: The Lockdown 
Around mid-March, the German government imposed several policies with the most prominent 
ones listed in Table 1. 
Table 1: Major Governmental Interventions 
Social Distancing Policies  Date Source 
Cancellation of Mass Gatherings 11.03.2020 (RKI, 2020b) 
School and Border Closures 16.03.2020 (RKI, 2020c) 
Closure of Non-Essential Stores 22.03.2020 (BReg, 2020a, 2020b) 
Contact Ban 22.03.2020 
Physical Distance 22.03.2020 
Face Masks 29.04.2020 (RKI, 2020d) 
Corona App 16.06.2020 (RKI, 2020g) 
Intensified Regulations for local “Hot Spots” 14.10.2020 (BReg, 2020d) 
 
As the estimations by Hartl et al. (2020) show, the pace of virus transmission already decreased 
around the 20th of March. Dehning et al. (2020) estimate that the approximated reproduction 
number R=1.15 in mid-march was less than half compared to the beginning of the pandemic. 
However, a reproduction number slightly above 1 means that several thousands of infected 
individuals again infect several thousands of new individuals. Therefore Dehning et al. (2020) 
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conclude, that besides interventions such as closure of schools or mass gathering bans, further 
restrictions were needed to finally suppress the virus transmission in Germany.  
In fact, on the 22nd of March 2020, the German government imposed three significant social 
distancing policies leading to nationwide lockdown: First, restaurants, museums and similar 
institutions and leisure activities were closed, with only the retail sector such as drugstores, 
supermarkets or pharmacies remaining open to supply the population (BReg, 2020a). Second, 
nationwide contact restrictions or contact bans were introduced, meaning that, with exceptions 
for families and households, only two persons were allowed to meet at the same time and it was 
required in public life to keep a physical distance of 1.5 meters between individuals (BReg, 
2020b). According to Dehning et al. (2020), it was due to these final measures that the 
reproduction number could be reduced below 1. Moreover, the effects of the social distancing 
measures introduced in mid-March were reflected in a change of individual behavior. As shown 
by Schlosser et al. (2020), individual mobility declined down to 40% in the respective period, 
meaning that individuals were less often on the move than before the lockdown. Thus, daily 
case numbers did not continue to grow, but new infections peaked in late March and early April 
2020 with a maximum of almost 7,000 new confirmed cases a day (JHU CSSE, 2020). 
Apart from that, in early April, there was still uncertainty whether the spread of the corona virus 
would lead to an overwhelming of the health care system and if it would come to so-called 
triage situations, in which critical case numbers are so high that physicians cannot guarantee 
sufficient care for all patients (Stang et al., 2020). However, according to data provided by the 
DIVI (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin), with a 
maximum of slightly more than 2,900 occupied beds during the first wave, the overall share of 
corona patients at the intensive-care-unit did not exceed the overall capacity, as more than 
10,000 beds were still available for medical treatment (compare DIVI, 2020). Notably, after 
some cities such as Jena or federal states like Saxony already started some days earlier, the 
wearing of face masks for public transport and shopping became mandatory for all federal states 
on the 29th April (RKI, 2020d).  
To summarize, in the lockdown period, case numbers dropped continuously. In May 2020, for 
the first time since mid-March, less than 1,000 daily infections were reported repeatedly and 
estimated active infections decreased by more than 70% from approximately 70,000 in April to 
less than 20,000 (compare JHU CSSE, 2020). 
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3.3. Phase III: The Post-Lockdown Period 
Eventually, the NPIs introduced in March and April 2020, leading to a nationwide lockdown, 
were relaxed gradually. While some restrictions such as the ban of mass gatherings or masks 
remained in place in most German regions, non-essential stores, educational and public 
institutions as well as many leisure activities reopened under certain restrictions (BReg, 2020c).  
As shown in Figure 1, despite those liftings, Germany did not immediately experience a 
significant rise in case numbers leading to a similar situation as compared to March or April. 
Case numbers increased only sporadically for a very short period. For example, infections in a 
meat production facility in North Rhine-Westphalia led to over 1,000 new cases, pushing the 
effective reproduction number above 1 and causing a temporal, local lockdown in the respective 
region (RKI, 2020e). In general, the course of infection in the post lockdown period might be 
partially driven by cluster infections, as the daily situational reports provided by the Robert-
Koch-Institute often register infections related to family parties or production facilities such as 
the above mentioned slaughterhouses (see for example RKI, 2020e, 2020i). As a note, 
compared to the peak of the pandemic in April, the CFR decreased during the post lockdown 
period from 4.7% to currently 2.8% in October 2020 (compare JHU CSSE, 2020). In other 
words, less persons died per documented infection in the months after the lockdown. The reason 
is that in earlier periods of the infection occurrence, the elderly accounted for a larger fraction 
of total infections, compared to later periods in which overall infections occurred more 
frequently in individuals younger than age 60 (RKI, 2020i). As discussed in previous chapters, 
age is an important variable when it comes to the likelihood of infected experiencing a more 
critical outcome.  
In summer 2020, the situation changed compared to the previous months of June and May, 
characterized by low infection numbers, as daily confirmed cases exceeded the one-thousand-
mark for several days in August 2020 (JHU CSSE, 2020), leading the RKI to state that the 
development is “concerning”  (RKI, 2020h, p. 1). The COVID-19 situation continued to 
deteriorate in Autumn 2020 and on the 15th of October, with 7,600 daily confirmed cases, the 
numbers reached an all-time high and thus exceeded the infection occurrence during the first 
wave followed by a nation-wide lockdown (JHU CSSE, 2020). Due to the resurgence of the 
virus, the German legislative agreed to intensify their COVID-19 strategy on the 14th of October 
2020 to especially target regional outbreaks exceeding a certain threshold of infections by 
implementing stricter regulations such as additional masking rules or contact restrictions 
(BReg, 2020d). At the beginning of October, a slightly positive trend in the number of daily 
deaths could be observed in the JHU CSSE (2020) data. However, it remains to be seen to what 
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extent this is a lasting trend and whether the death numbers will return to the level observed 
during the first wave. 
4.  The Theoretical Model 
In order to trace the described development of the pandemic, we apply a highly stylized 
theoretical model, the so-called SIRDH model. It consists of the dynamic transitions between 
the states S (susceptible), I (infected), R (removed), D (death), and H (immune healthy). With 
respect to the phase I, we use the basic model with time-invariant transition rates. The phases 
II and III, however, are characterized by governmental interventions, ranging from the 
introduction to the relaxation of requirements. Therefore, we will use an extended version of 
the model with time-dependent transition rates. 
4.1. The Basic SIRDH Model with Time-Invariant Transition Rates 
The classical SIR models are based on the work by Kermack and McKendrick (1927) and are 
since then widely used to analyze the spread of diseases of the last two centuries (Hethcote, 
2008; Z. Ma, 2009). Among many others, the standard SIR model or variations of it are used to 
study notable infectious diseases such as the well-known influenza virus in 1918 and more 
recently for research in Ebola or the SARS outbreak in 2003 (see e.g. Chowell et al., 2004; Ng 
et al., 2003; Weitz & Dushoff, 2015; Yu et al., 2017). Since the beginning of the COVID-19 
pandemic in China in late December 2019, there exists a wide range of studies based on the 
SIR type models to calibrate or predict the spread of the novel corona virus. The specification 
of these models has to be adapted to basic characteristics of the COVID-19 pandemic as 
reported above: At first this means that an appropriate model must be able to capture the 
dynamic process of the spread of the virus under changing circumstances such as governmental 
interventions and relaxations of these interventions (e.g. Atkeson, 2020; James et al., 2020). 
Second, it should be able to provide information about the critical share of the population that 
must be infected in order for the whole population to acquire herd-immunity (Britton et al., 
2020) or information about some key epidemiological indicators such as the (basic) 
reproduction number (R. Li et al., 2020). Dehning et al. (2020) use the SIR model to assess for 
Germany how NPIs reduced the infection rate and how the pandemic might have developed if 
the government had reacted in a different way to the spread of the virus. Toda (2020) provides 
similar estimations for the infection rate for the period of late March 2020 for about 30 
countries. Similar, adding a death compartment to the equations, Fernández-Villaverde & Jones 
(2020) provide an analysis about the mortality of COVID-19 including various countries as 
13 
 
well as certain regions such as the City of New York, Madrid or Stockholm. As a note, some 
studies such as Toda (2020) combine epidemiological and economic features to assess which 
governmental intervention strategy may be the best. Moreover, various studies show how a 
variable infection rate can be used to account for the use of NPIs. For example, Atkeson (2020) 
and Baker (2020) describe from a theoretical perspective how time-dependent transmission 
rates change the dynamics of the SIR model and Rossi and Ianni (2020) show that it is possible 
to use a decreasing exponential function to simulate the COVID-19 development in Italy. In 
sum, these studies demonstrate that adequately adapted SIR models are very appropriate to 
simulate the current COVID-19 pandemic. 
We use a variant of the model of Fernández-Villaverde and Jones (2020) to simulate the 
COVID-19 pandemic in Germany. The transition dynamics of the model, here referred to as 
the SIRDH model, is represented in Figure 2 
 
 
 
 
 
 
 
At the beginning of the process, nearly the whole population N consists of susceptible 
individuals S. This means that, in the absence of vaccination, anyone can be potentially infected 
with the virus (WHO, 2020c). Susceptible may get the COVID-19 disease via contact with 
infected individuals for example through droplets or aerosol transmission. These contacts are 
captured by the infection rate β. The infected compartment I refers to those who are exposed to 
SARS-CoV-2. At the rate 𝛾𝛾, these individuals lose their infectivity and remove from state I to 
state R. It is assumed that those who are removed from the disease acquire immunity rendering 
a re-infection with the same virus impossible. Moreover, after a period of  1
𝜃𝜃
 days on average, 
implying the exit rate 𝜃𝜃, the individuals move either to the dead compartment (D) with 
probability 𝛿𝛿 or to the healthy compartment (𝐻𝐻) with the counter probability 1 − 𝛿𝛿. The five 
components sum up to 𝑆𝑆(𝑡𝑡) + 𝐼𝐼(𝑡𝑡) + 𝑅𝑅(𝑡𝑡) + 𝐷𝐷(𝑡𝑡) + 𝐻𝐻(𝑡𝑡) = 𝑁𝑁, where the population size N is 
assumed to be time-invariant. This pandemical dynamics is described by the following set of 
differential equations: 
(1-δ)θ 
H 
I R S 
D 
β
 
γ
 
δθ 
Figure 2: Transition Dynamics of the SIRDH Model 
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𝑑𝑑𝑆𝑆
𝑑𝑑𝑡𝑡
=   −𝛽𝛽 
𝐼𝐼𝑆𝑆
𝑁𝑁
,               𝛽𝛽 > 0 (1) 
𝑑𝑑𝐼𝐼
𝑑𝑑𝑡𝑡
=   𝛽𝛽 
𝐼𝐼𝑆𝑆
𝑁𝑁
− 𝛾𝛾𝐼𝐼, 0 < 𝛾𝛾 < 𝛽𝛽 (2) 
𝑑𝑑𝑅𝑅
𝑑𝑑𝑡𝑡
=   𝛾𝛾𝐼𝐼 − 𝜃𝜃𝑅𝑅,   𝜃𝜃 > 0 (3) 
𝑑𝑑𝐷𝐷
𝑑𝑑𝑡𝑡
=  𝛿𝛿𝜃𝜃𝑅𝑅,                   0 < 𝛿𝛿 < 1 (4) 
𝑑𝑑𝐻𝐻
𝑑𝑑𝑡𝑡
= (1 − 𝛿𝛿)𝜃𝜃𝑅𝑅  (5) 
 
At the beginning of the pandemic, it holds that 𝑆𝑆(0) ≈ 𝑁𝑁 so that (2) can be rewritten as 
 𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= ( 𝛽𝛽 − 𝛾𝛾)𝐼𝐼.  
This differential equation implies exponential growth at the constant rate (𝛽𝛽 − 𝛾𝛾). Later on, the 
time path for the number of infected individuals is given by the differential equation 
𝑑𝑑𝐼𝐼
𝑑𝑑𝑡𝑡
=   𝛾𝛾𝐼𝐼(𝑅𝑅𝑒𝑒 − 1), (6) 
where 𝑅𝑅𝑒𝑒 =  
𝛽𝛽
𝛾𝛾
𝑆𝑆
𝑁𝑁
 is the effective reproduction number and 𝑅𝑅0 =  
𝛽𝛽
𝛾𝛾
 is the basic reproduction 
number at the beginning of the pandemic when 𝑆𝑆(0)
𝑁𝑁
≈ 1. As can be seen from (6), in the case 
of 𝑅𝑅𝑒𝑒 > 1   the virus spreads through the whole population.  
 
Given the short-run capacity constraints of the hospitals’ intense care units, it is very important 
to calculate the maximum number 𝐼𝐼𝑚𝑚𝑚𝑚𝑚𝑚 of infected persons. Due to the separability of the 
differential equations (1) and (2), we are able to solve the SIRDH model with respect to this 
number. Division of (2) by (1) gives 
𝑑𝑑𝐼𝐼
𝑑𝑑𝑆𝑆
=  
𝑑𝑑𝐼𝐼/𝑑𝑑𝑡𝑡
𝑑𝑑𝑆𝑆/𝑑𝑑𝑡𝑡
=
𝑅𝑅0
𝑆𝑆
 − 1. 
 
Integration with respect to S leads to 
𝐼𝐼(𝑆𝑆) =  𝑅𝑅0 ln 𝑆𝑆 − 𝑆𝑆 + 𝐴𝐴.  
Due to the initial condition 𝐼𝐼(𝑆𝑆 = 𝑁𝑁) =  𝑅𝑅0 ln𝑁𝑁 − 𝑁𝑁 + 𝐴𝐴 = 0, we obtain for the constant of 
integration 𝐴𝐴 = 𝑁𝑁 −  𝑅𝑅0 ln𝑁𝑁 so that 
𝐼𝐼(𝑆𝑆) =  𝑅𝑅0 ln(𝑆𝑆/𝑁𝑁) + 𝑁𝑁 − 𝑆𝑆.  
The first-order condition for the unique maximum of I(S) requires 𝑆𝑆 = 𝑅𝑅0 and hence 
𝐼𝐼𝑚𝑚𝑚𝑚𝑚𝑚(𝑆𝑆 = 𝑅𝑅0) =  1 − (1 + ln𝑅𝑅0)/𝑅𝑅0. (7) 
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By using the basic reproduction number, it is also possible to derive another key 
epidemiological parameter, namely the herd immunity threshold ℎ = (𝑁𝑁 − 𝑆𝑆ℎ)/𝑁𝑁. This 
threshold value indicates the share of the immunologically healthy population that is necessary 
to avoid the spread of the pandemic. Since this critical value is given by 𝑅𝑅𝑒𝑒 =
𝑅𝑅0𝑆𝑆ℎ
𝑁𝑁
= 1 , one 
obtains 𝑆𝑆ℎ = 𝑁𝑁/𝑅𝑅0 and thus 
ℎ = 1 −
1
𝑅𝑅0
. (8) 
Herd immunity may not only be reached through individuals becoming infected and recovered 
but also with the help of vaccination. Therefore, (8) equivalently corresponds to the share of 
the population needed to be vaccinated such that the number of infected individuals 
𝐼𝐼(𝑡𝑡) declines over time (van den Driessche, 2017). 
 
 
Figure 3: Numerical Simulation of a Pandemic Development 
A numerical example of the SIRDH dynamics is illustrated in Figure 3. Here, the total 
population is standardized to N=1. The initial conditions are given by 𝑆𝑆(0) = 0.99 and 𝐼𝐼(0) =
0.01. The transition rates are given by 𝛽𝛽 = 0.3 and 𝛾𝛾 = 𝜃𝜃 = 0.1 leading to the basic 
reproduction number of 𝑅𝑅0 = 3. The maximum share of infected people is calculated as 𝐼𝐼𝑚𝑚𝑚𝑚𝑚𝑚 ≈
0.3 and the threshold value for herd immunity corresponds to the share ℎ ≈ 0.67 of 
immunologically healthy persons. The probability of death is given by 𝛿𝛿 = 0.01. This implies 
that, in the long run, the population converges to the share 𝐻𝐻 = 0.99 of immunologically 
healthy people and the share D= 0.01 of deceased people.  
 
0,000
0,001
0,002
0,003
0,004
0,005
0,006
0,007
0,008
0,009
0,010
0,0
0,2
0,4
0,6
0,8
1,0
1,2
0 25 50 75 100
Sh
ar
e 
of
 T
ot
al
 D
ea
th
s (
D)
Sh
ar
e 
of
 T
ot
al
 P
op
ul
at
io
n 
(S
,I,
R,
H)
S I R H D
16 
 
4.2. The SIRDH Model with Time-Dependent Infection and Mortality Rates 
 
The model described so far is characterized by fixed parameter values for all transition rates. 
However, for several reasons this is not true for the second and third phases of the COVID-19 
pandemic. Of course, all governments reacted more or less to the development and imposed 
various restrictions to condemn the spread of SARS-CoV-2. Moreover, even without 
governmental policy, the individuals as a whole adapt their behavior during pandemics in order 
to lower the transmission of the virus (for earlier infection disease outbreaks see e.g. Funk et 
al. (2009) and R. Liu et al. (2007)). For this reason, we relax the assumption of fixed transition 
rates and introduce a time-dependent infection rate 𝛽𝛽(𝑡𝑡) as well as a time-dependent mortality 
𝛿𝛿(𝑡𝑡). 
To specify a variable infection rate 𝛽𝛽(𝑡𝑡), we follow the approach of Chowell et al. (2004) and 
assume a fixed transmission rate 𝛽𝛽0 in the first phase and a decreasing logistic function for the 
second6. Additionally, we use an increasing logistic function for the third phase. This allows us 
to capture the three main stages of the German pandemic, namely the pre-lockdown, lockdown, 
and the post-lockdown period. We specify the development of the infection rate as 
 
 
𝛽𝛽(𝑡𝑡) = 
𝛽𝛽0   𝑓𝑓𝑓𝑓𝑓𝑓 𝑡𝑡 ≤ 𝑙𝑙 (9) 
𝛽𝛽1 + (𝛽𝛽0 − 𝛽𝛽1)𝑒𝑒−𝑘𝑘1(𝑑𝑑−𝑙𝑙)   𝑓𝑓𝑓𝑓𝑓𝑓 𝑙𝑙 <  𝑡𝑡 ≤ 𝑚𝑚 (10) 
𝛽𝛽2 − (𝛽𝛽2 − 𝛽𝛽1)𝑒𝑒−𝑘𝑘2(𝑑𝑑−𝑚𝑚)  𝑓𝑓𝑓𝑓𝑓𝑓 𝑚𝑚 < 𝑡𝑡 (11) 
  
where 𝑙𝑙 and 𝑚𝑚 correspond to the lockdown and lifting dates and the parameters 𝛽𝛽1 < 𝛽𝛽2 <
𝛽𝛽0, and 𝑘𝑘1, 𝑘𝑘2 > 0  determine the time path of the infection rate. With respect to the mortality 
rate, we assume two periods and specify the development as 
𝛿𝛿(𝑡𝑡) = 
𝛿𝛿0   𝑓𝑓𝑓𝑓𝑓𝑓 𝑡𝑡 ≤ 𝑚𝑚 (12) 
𝛿𝛿1 + (𝛿𝛿0 − 𝛿𝛿1)𝑒𝑒−𝑘𝑘3(𝑑𝑑−𝑚𝑚)   𝑓𝑓𝑓𝑓𝑓𝑓 𝑡𝑡 > 𝑚𝑚 (13) 
where the parameters 𝛿𝛿1 < 𝛿𝛿0 and 𝑘𝑘3 > 0 determine the time path of the mortality rate. As the 
mortality rate was relatively high in the phases I and II but declined during phase III, 𝛿𝛿(𝑡𝑡) starts 
to decrease at the same date m as the lifting date in (11) does. 
                                                 
6 Chowell et al. (2004) show how governmental interferences during a past Ebola outbreak in Africa are associated 
with a reduction of the reproduction number. 
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5. Application of the SIRDH Model on the Development in Germany 
The following empirical analysis is based on discrete time, whereby one period corresponds to 
one day. 
5.1. Time-Invariant Infection and Mortality Rates 
As a first step, we simulate a hypothetical scenario, in which the transition of SARS-CoV-2 
corresponds to the pre-lockdown period during phase I of the pandemic in Germany. It is 
assumed that the spread of the virus is not influenced through behavioral adaptions or 
governmental interferences as a response to COVID-19. We set the parameters as follows (see 
the Appendix for the calibration of all variables and parameters): Regarding the infectivity 
period we choose a value of 10 days leading to 𝛾𝛾 = 0.1 (compare He et al., 2020; Kampen et 
al., 2020; Singanayagam et al., 2020; Wölfel et al., 2020). For the less critical COVID-19 
patients it takes about two weeks to fully recover from the illness (WHO, 2020c) which led us 
to set 𝜃𝜃 ≈ 0.25. For the infection rate we considered the time between January and mid-March 
2020 and fitted it to the data provided by JHU CSSE (2020). This led us to set a constant value 
of 𝛽𝛽 = 0.3 resulting in a basic reproduction number of 𝑅𝑅0 = 3. Finally, we compared three 
different values for the mortality rate δ given by 0.005, 0.01 and 0.015 which is within the range 
of several reports estimating the infection fatality rate (IFR) of COVID-19 (compare Davies et 
al., 2020; Pastor-Barriuso et al., 2020; Russell et al., 2020; Salje et al., 2020; Verity et al., 2020; 
Ward et al., 2020). The graphical solutions of the simulations are shown in the figures below. 
 
Figure 4: Simulated Daily Infections vs. Real Development in Phase I 
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As can be seen in Figure 4, a reproduction number of 3 yields a good approximation of daily 
infections until the 21st of March 2020. However, from there on, the simulation starts to take 
off, leading to tens of thousands of infections by the end of March. This trend continues 
resulting in more than 3,000,000 infections per day in May 2020. 
 
Figure 5: Hypothetical Active Infections  
During the peak of the hypothetical scenario, a maximum share of about 30% of the German 
population is infected corresponding to around 26,000,000 of exposed individuals at the same 
time (see Figure 5). Taking Clark's calculations as an approximation that about 6% of the 
population needs to be transferred to the hospital after an infection indicates that health care 
systems in Germany would be at high risk to be overwhelmed. In this scenario, with millions 
of infections, the German population eventually reaches herd immunity, and the number of 
infections declines. Thus, the virus disappears by itself in the long run.  
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Figure 6: Hypothetical Total Infections 
By Autumn 2020, with almost 80,000,000 total infections, almost the entire German population 
got exposed to SARS-CoV-2 (see Figure 6). In contrast, assuming that a successful vaccine 
distribution for about 67% (≈ 55,000,000) of the population would have been available at the 
beginning of the outbreak, the spreading of the virus would have been immediately stopped 
after the first infections.  
 
Figure 7: Hypothetical Total Deaths 
Finally, figure 7 shows the development of total deaths for the three infection-fatality-rates of 
0.5%, 1% and 1.5%. Depending on the rate, this results in approximately 400,000 to 1,200,000 
total deaths by the end of the pandemic.  
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5.2. Time-Dependent Infection and Mortality Rates 
Let us now relax the assumption of time-invariant infection and mortality rates and instead 
calibrate β(t) and δ(t) to the data provided by JHU CSSE (2020). All remaining parameters are 
set as shown above.  
To simulate the overall development of COVID-19 cases in Germany, we make two 
simplifications. First, we assume that the effective reproduction number is constant during the 
pre-lockdown period. Second, we interpret the post-lockdown period as a slow, but gradual 
increase of the reproduction number and exclude any ups and downs of daily case numbers. As 
above, we set 𝛽𝛽0 to be 0.3 in phase I which is kept constant until late March 2020.  
 
Figure 8: Simulated Reproduction Number 
By the end of March, we reduced 𝛽𝛽0 gradually to 𝛽𝛽1 = 0.059. Here, the reproduction number 
is pushed to a minimum value of 𝑅𝑅𝑒𝑒 ≈ 0.59 which is reached in early May 2020. This 
development covers the lockdown-period. Afterwards, we increased 𝛽𝛽1 again starting in mid-
May which marks the beginning of the post-lockdown period. Eventually, the infection rate 
gradually converges towards 𝛽𝛽2 = 0.14. This increase leads to the fact that in mid-October 𝑅𝑅𝑒𝑒 
corresponds to around 1.3 (see Figure 8).  
Finally, we simulated the total deaths of the pandemic in Germany.  Regarding the pre- and 
lockdown period we assume a constant mortality rate of 𝛿𝛿0 = 0.0485.7 Afterwards, the rate 
                                                 
7 In this version, the mortality rate corresponds to the case-fatality rate as only documented cases are considered. 
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declines in the post-lockdown period and eventually reaches 𝛿𝛿1 = 0.007. The graphical 
solutions are presented in the figures below.  
 
Figure 9: Simulated Daily Infections vs Real Development 
As Figure 9 shows, the extended SIRDH model provides a good fit between the simulation and 
the data. Similar to the previous analysis, the first wave equals an inverted U-shape. However, 
due to the variable infection rate, the daily case numbers are significantly lower and do not 
exceed 7,000 daily infections in the first wave. As 𝑅𝑅𝑒𝑒 is pushed below 1 in the lockdown period 
case numbers eventually decline. However, in the long run it is given that 𝑅𝑅𝑒𝑒 >1 and thus the 
growth rate of new infections is positive, leading to a second wave of COVID-19 infections. 
 
Figure 10: Simulated Total Deaths vs. Real Development 
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As a result of the time-dependent infection and mortality rates, it is also possible to reconstruct 
the development of total deaths and total confirmed infections quite accurate (see Figure 10 and 
11).  
 
 
Figure 11: Simulated Total Cases vs. Real Development 
 
6. Summary and Conclusion 
This paper dealt with the emergence of COVID-19 and investigated how the development of 
the disease in Germany can be ex-post simulated by applying a combination of the basic and an 
extended SIRDH model. We summarized the development of the COVID-19 crisis and 
presented key characteristics of SARS-CoV-2. In a very stylized but helpful setting, we 
distinguished three different phases. The first phase refers to the pre-lockdown stage 
characterized by exponential growth. The second phase corresponds to the time between March 
and May 2020 in which the German government controlled the infection process by 
implementing various non-pharmaceutical interventions leading to a nationwide lockdown. 
Finally, the third post-lockdown stage describes the gradual relaxation of restrictions which led 
to a revival of the virus in late Summer/Autumn 2020. This time structure laid the foundation 
for our design of the epidemiological model. 
Based on Fernández-Villaverde & Jones (2020), we first simulated the SIRDH model using 
time-invariant transition rates. The results serve as a “what if” analysis and show that without 
any behavioral or governmental interventions, a spread of COVID-19 would potentially lead to 
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several millions of infections, at the same time accompanied by hundreds of thousands of 
deaths. 
The findings are in line with the results of Flaxman et al. (2020) who estimate that over 500,000 
Germans could have died by May 2020, if the spread of the virus would not have been 
suppressed by social distancing policies. These results are backed up by Ferguson et al. (2020) 
who calculate similar death numbers for the UK and the US and state that intensive care unit 
capacities would not have been enough, if the virus would have spread rapidly through the 
population. Such estimations are only hypothetical, and our results need to be interpreted with 
caution. However, they serve as a benchmark to show the potential unfolding dynamics of 
COVID-19. 
To include a decreasing case fatality rate, observed during the post-lockdown period, and to 
account for the fact that the German government imposed several social distancing policies to 
fight the spread of the virus, the SIRDH model was modified with respect to time-dependent 
infection and mortality rates. The use of a first constant, then decreasing, and finally increasing 
infection rate allowed us to model the pandemic in Germany regarding daily new and total 
infections and deaths quite accurate.  
An interesting extension of our approach would be to include a cosine function in order to allow 
for oscillating infection rates. Such an approach is for example used to account for seasonality 
effects of other infectious diseases such as measles (Chen & Epureanu, 2017) or influenza 
(Dushoff et al., 2004) and is also applied to model the current COVID-19 pandemic (Neher et 
al., 2020). Furthermore, we assumed that individuals acquire permanent immunity after an 
infection. While we showed that this rationale can unproblematically be used to reconstruct the 
development of the first and second corona waves in 2020, it remains to be seen whether this 
assumption is also valid in the long run. The study by To et al. (2020) has confirmed that it is 
possible to be infected again after being exposed to the virus. If this turns out to be a regular 
pattern, it will be necessary to further extend our SIRDH version to a SIRDHS version, in which 
infected individuals lose their immunity after a certain period of time and move back to the 
susceptible state S (see, e.g. Hethcote (2008)). 
These alternatives may become increasingly important when no effective vaccine will be 
developed and distributed in the near future. However, during the final editing of this paper, it 
has become known that effective vaccination is very likely to be available in the first half of 
2021. Let us hope the best. 
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Appendix 
 
Calibrated Values for the Variables and Parameters 
 Note/Source 
Total Population N 83.783.942 Worldometer (2020) 
Initial Conditions for the Variables 
Susceptible S(0) 83.783.941 = N-I(0)-R(0)-H(0)-D(0) 
Infected I(0) 1 JHU CSSE (2020) 
Removed R(0) 0  
Healthy H(0) 0  
Dead D(0) 0  
Fixed Parameter Values 
Duration of Infectivity 
 
10 days 
He et al. (2020, p. 672), 
Kampen et al. (2020, p. 2), 
Singanayagam et al. (2020, 
p. 1), Wölfel et al. (2020, p. 
466) 
Removing Rate 𝛾𝛾 =
1
10
= 0.1  
Duration until 
Recovery or Death 
 4 days WHO (2020c, p. 14) 
Exit Rate from the 
State R 
θ 
 
=
1
4
= 0.25  
Mortality Rate 
(Infection Fatality 
Rate) 
δ 0.005-0.015 
compare Davies et al., 
(2020, p. 379); Pastor-
Barriuso et al., (2020, p. 4); 
Russell et al., (2020, p. 3); 
Salje et al., (2020, p. 369); 
Verity et al., (2020, p. 675); 
Ward et al., (2020, p. 7). 
Fitted Parameter Values 
Pre-Lockdown 
Infection Rate 𝛽𝛽0 0.3  
Lockdown Infection 
Rate 𝛽𝛽1 0.059  
Lockdown Parameter 𝑘𝑘1 0.15  
Lockdown Date 𝑙𝑙 54 21.03.2020 
Post-Lockdown 
Infection Rate 𝛽𝛽2 0.14  
Lifting Parameter 𝑘𝑘2 0.014  
Lifting Date 𝑚𝑚 105 11.05.2020 
Mortality Rate in 
Phases I and II (Case 
Fatality Rate)  
𝛿𝛿0 0.0485 
 
Mortality Rate in 
Phase III (Case 
Fatality Rate)  
𝛿𝛿1 0.007 
 
Mortality Parameter 𝑘𝑘3 0.03  
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